Bank of Montreal’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-54,069
| Closed | -$9.55M | – | 4053 |
|
|
2021
Q3 | $9.55M | Sell |
54,069
-143,740
| -73% | -$18.8M | ﹤0.01% | 1330 |
|
|
2021
Q2 | $25.1M | Buy |
197,809
+195,265
| +7,676% | +$24.6M | 0.01% | 791 |
|
|
2021
Q1 | $329K | Buy |
2,544
+449
| +21% | +$58K | ﹤0.01% | 2885 |
|
|
2020
Q4 | $245K | Sell |
2,095
-16
| -0.8% | -$1.88K | ﹤0.01% | 3120 |
|
|
2020
Q3 | $232K | Sell |
2,111
-394
| -16% | -$39.2K | ﹤0.01% | 2680 |
|
|
2020
Q2 | $252K | Buy |
2,505
+151
| +6% | +$14.6K | ﹤0.01% | 2612 |
|
|
2020
Q1 | $197K | Sell |
2,354
-6,246
| -73% | -$486K | ﹤0.01% | 2334 |
|
|
2019
Q4 | $457K | Buy |
8,600
+4,339
| +102% | +$198K | ﹤0.01% | 2720 |
|
|
2019
Q3 | $168K | Buy |
4,261
+339
| +9% | +$14.7K | ﹤0.01% | 3016 |
|
|
2019
Q2 | $161K | Buy |
3,922
+3,830
| +4,163% | +$159K | ﹤0.01% | 3051 |
|
|
2019
Q1 | $4K | Sell |
92
-1,592
| -95% | -$69.9K | ﹤0.01% | 4077 |
|
|
2018
Q4 | $73K | Sell |
1,684
-207
| -11% | -$10.3K | ﹤0.01% | 3110 |
|
|
2018
Q3 | $108K | Buy |
1,891
+1,290
| +215% | +$63.4K | ﹤0.01% | 3062 |
|
|
2018
Q2 | $29K | Buy |
601
+275
| +84% | +$10K | ﹤0.01% | 3626 |
|
|
2018
Q1 | $13K | Sell |
326
-1,144
| -78% | -$48.6K | ﹤0.01% | 3688 |
|
|
2017
Q4 | $62K | Hold |
1,470
| – | – | ﹤0.01% | 3192 |
|
|
2017
Q3 | $55K | Sell |
1,470
-7,501
| -84% | -$260K | ﹤0.01% | 3189 |
|
|
2017
Q2 | $273K | Hold |
8,971
| – | – | ﹤0.01% | 2504 |
|
|
2017
Q1 | $237K | Buy |
+8,971
| New | +$236K | ﹤0.01% | 2387 |
|
|
2015
Q1 | – | Sell |
-6,700
| Closed | -$261K | – | 4267 |
|
|
2014
Q4 | $261K | Buy |
+6,700
| New | +$234K | ﹤0.01% | 2365 |
|
|
2014
Q3 | – | Sell |
-180
| Closed | -$6K | – | 4543 |
|
|
2014
Q2 | $6K | Buy |
+180
| New | +$6.02K | ﹤0.01% | 4115 |
|
Bank of Montreal's XLRN Position: Q4 2021 in Review
Bank of Montreal sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 54,069 shares — an estimated $9.55M sold.
Bank of Montreal first reported a position in XLRN in Q2 2014 and held it in 21 quarters. The position peaked at $25.1M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Bank of Montreal reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Bank of Montreal sold 54,069 Acceleron Pharma shares in Q4 2021, an estimated $9.55M.
- Bank of Montreal first reported a position in Acceleron Pharma in Q2 2014 and held it in 21 quarters.
- Bank of Montreal's Acceleron Pharma position peaked at $25.1M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.